Financing Strategies of Influenza Vaccination in China

Peking University

Status: Completed

Conditions: Influenza, Human; Cost of Illness; Immunization Programs; Influenza Vaccines; Health Knowledge, Attitudes, Practice

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT04038333

IRB00001052-19076

Details and patient eligibility

About

This trial focuses on influenza vaccination among three recommended groups in China. Data concerning the economic burden of influenza-like illness (ILI), vaccine hesitancy, discrete choice experiment, immunization records and willingness to pay for vaccines will be collected via questionnaires, and the financing strategies of influenza vaccines in China will be further analyzed. Besides, the knowledge, attitude/belief and practice (KAP) of medical staff will also be asked in a supplementary questionnaire.

Full description

This trial focuses on influenza vaccination among three recommended groups in China, including children (aged between 6 to 59 months), the elderly (aged 60 years old or above), and adult patients with chronic diseases (aged below 60 years old).

The questionnaires will collect data on the economic burden of influenza-like illness (ILI), vaccine hesitancy, discrete choice experiment, immunization records and willingness to pay for vaccines, and the financing strategies of influenza vaccines in China will be further analyzed accordingly.

Besides the three recommended groups, vaccination and health care personnel will also be asked about their knowledge, attitude/belief and practice (KAP) in a supplementary questionnaire.

Enrollment: 13,542 patients

Sex: All

Ages: 6+ months old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• (For children group) children aged between 6 to 59 months.
• (For the elderly group) the elderly aged 60 years old or above.
• (For chronic disease patient group) adult patients with chronic diseases aged below 60 years old.
• (For medical staff) general practitioners and vaccination staff.
• Interviewees with informed consent.

Exclusion criteria

• Those cannot be surveyed for physical reasons.
• Those with communication barriers.
• Those who do not agree to participate in the survey.

Trial design

13,542 participants in 4 patient groups

Children

Description:

Interviewees are parents or grandparents of children aged between 6 to 59 months.

Treatment:

Other: No intervention

Elderly

Description:

Interviewees are the elderly aged 60 years old or above.

Treatment:

Other: No intervention

Chronic disease patients

Description:

Interviewees are adult patients with chronic diseases aged below 60 years old.

Treatment:

Other: No intervention

Vaccination and health care personnel

Description:

Interviewees are vaccination and health care personnel in each study site.

Treatment:

Other: No intervention